Will Insurance Pay for Red Light Therapy? Coverage, Costs, and Eligibility

Last updated: October 10, 2026

Before buying a device or booking treatment, ask: will insurance pay for red light therapy? Checking first helps you understand benefit exclusions, authorization requirements, documentation, and claim deadlines before committing to an expense.

Do not assume that a home red light therapy device or a clinic session is covered. Some U.S. insurers allow specific clinical uses, such as low-level laser therapy for prevention of oral mucositis during certain cancer treatments, while excluding many other uses. Aetna's policy provides one example; it is not a guarantee for every member or insurer. FDA clearance, a prescription, and a diagnosis code do not independently establish insurance eligibility. Aetna CPB 0363

This article focuses on U.S. health insurance, Medicare, and HSA/FSA arrangements. It explains how to check your plan, distinguish manufacturer credentials from coverage evidence, and prepare a useful request. Policies and coding requirements can change; confirm the rules that apply to your plan and service date.

Why insurers almost always say "experimental" — and what that really means

5 Reasons Insurers Label Red Light Therapy 'Experimental' and Deny Coverage 1

Insurance coverage pathway diagram for red light therapy decisions

Will insurance pay for red light therapy? The answer depends on the exact service, indication, and benefit plan. "Experimental," "investigational," and "unproven" are coverage terms used when a payer considers the evidence insufficient for a particular use. Other denials may involve a benefit exclusion, missing information, an out-of-network provider, or an authorization requirement.

For example, Aetna's cold laser policy distinguishes oral mucositis prevention from numerous investigational indications, including several pain conditions and wound healing. Read the indication-specific policy rather than relying on a general statement that light therapy is covered. Aetna CPB 0363

Regulatory status answers a separate question: what requirements apply to marketing this device for its intended use?

Term	What it actually means	Coverage relevance
FDA-cleared through 510(k)	FDA determined substantial equivalence to a legally marketed predicate for the device's intended use.	Check the exact model and labeling; clearance alone does not require reimbursement.
FDA establishment registration and device listing	Administrative records identifying an establishment and its device activities.	These records do not establish approval, clearance, or clinical effectiveness.
CE / RoHS	CE concerns conformity with applicable European requirements; RoHS concerns restrictions on certain hazardous substances in applicable equipment.	Neither establishes a U.S. insurance benefit or medical-necessity determination.

FDA explicitly states that registration and listing do not denote approval, clearance, or authorization. Check the actual device record and intended use instead of treating "FDA registered" as a clinical endorsement. FDA registration and listing reminders

The evidence bar payers actually use

Payers assess evidence for a defined population, treatment protocol, and outcome. Randomized trials and systematic reviews can inform those decisions, but there is no universal rule that a particular evidence level automatically produces coverage.

A positive study in one setting does not establish reimbursement for another. Research on intraoral photobiomodulation during cancer treatment, for example, cannot simply be substituted for evidence about a home panel used for general wellness. Providence's policy illustrates this distinction: its coverage criteria identify oral mucositis prevention while finding insufficient support for other laser-therapy uses. Providence MP201

Diagnosis coding identifies the condition; it does not prove efficacy. A qualified clinician or coder should select the appropriate current ICD-10-CM code. Broad categories such as L40 for psoriasis and L70 for acne are not a substitute for the complete code and clinical record required for a particular claim.

Where coverage does exist in limited form

Prevention of oral mucositis during specified cancer treatments is a documented example of a potentially covered clinical use. Providence's policy includes chemotherapy, radiotherapy, and hematopoietic stem cell transplantation in its criteria. It distinguishes prevention from treatment of established mucositis, showing why the wording of the proposed service matters. Eligibility still depends on the member's benefit plan. Providence MP201

Wound care should not be presented as a generally covered red light therapy exception. Medicare NCD 270.6 states that infrared and/or near-infrared light and/or heat is non-covered for diabetic or non-diabetic peripheral sensory neuropathy and for wounds or ulcers of the skin or subcutaneous tissues, including associated symptoms such as pain. This is an indication-specific national policy, not a statement about every light-based procedure. CMS NCD 270.6

A clinical laser service and a consumer LED panel are not interchangeable for reimbursement purposes. Neither a clinician's involvement nor an FDA device classification automatically establishes coverage. Understanding how to bill for red light therapy in physical therapy settings requires review of the actual modality, current codes, provider eligibility, and payer rules. CPT 97026 refers to infrared therapy; it is not a universal reimbursement code for photobiomodulation. CMS outpatient therapy billing guidance

What device documentation actually signals to a payer

5 Reasons Insurers Label Red Light Therapy 'Experimental' and Deny Coverage 2

Red light therapy panel beside separate regulatory records and an optical test report

The most useful submission documents are those that address the plan's requirements: the clinical indication, proposed service, relevant medical records, and applicable device labeling. Manufacturer credentials support supplier verification, but they should not be presented as proof that an insurer will pay.

When reviewing device documentation, distinguish FDA establishment registration, ISO 13485 certification, and MDSAP certification. Each has a specific scope and should be described accurately.

Step 1: Understand what each credential certifies.

FDA establishment registration identifies the facility in the relevant administrative system. Device listing is a separate requirement where applicable; neither is an FDA safety or efficacy endorsement.
ISO 13485 certification concerns a medical-device quality management system within the certificate's stated scope.
MDSAP allows a recognized auditing organization to assess a manufacturer's quality management system against participating regulators' requirements through a single audit program.

These distinctions follow the FDA registration guidance, ISO 13485 standard description, and FDA MDSAP overview.

Step 2: Know what these credentials do not certify.

They do not establish that a particular panel treats a specific diagnosis, that every product holds the same market authorization, or that an expense qualifies for reimbursement. Match each document to the manufacturer, certificate scope, model, intended use, and relevant market.

Step 3: Ask for spectral measurement data alongside compliance documents.

For technical evaluation, LED Wavelength Measurement Best Practices should include measured peak wavelength, deviation from nominal wavelength, full width at half maximum (FWHM), and an irradiance report identifying the distance, operating mode, measurement plane, instrument, calibration, and warm-up conditions. Average, peak, uniformity, and thermal-stability results help describe actual output.

These are engineering records, not universal insurance submission requirements. They are useful when assessing whether a device can reproduce a proposed protocol. Published photomedicine reporting guidance emphasizes verification and disclosure of beam and dose parameters to support reproducibility. Jenkins and Carroll, 2011

Step 4: Match the credential to the claim being made.

If a product is represented as FDA-cleared, request its clearance number and corresponding labeling. Where an exemption or another pathway applies, ask for the classification and regulatory basis. Do not assume every legally marketed device must have a 510(k) number: FDA identifies exemptions and other pathways in its guidance. FDA 510(k) overview

ISO 13485 and MDSAP: what they certify and what they do not

ISO 13485 specifies quality management requirements for organizations providing medical devices and related services. Verify the activities and locations covered by the actual certificate. Certification does not independently establish clinical efficacy or insurance coverage. ISO 13485:2016

The MDSAP member authorities are those of Australia, Brazil, Canada, Japan, and the United States. The European Union is an official observer; MDSAP does not itself provide EU market authorization. Audit participation also does not replace each jurisdiction's applicable product requirements. FDA MDSAP overview

The FDA-registered vs. FDA-cleared gap — explained plainly

Registration and listing are administrative requirements where applicable. A 510(k) clearance is a device-specific substantial-equivalence determination. Premarket approval (PMA) is a different process evaluating the safety and effectiveness of Class III devices. These terms should not be used interchangeably. FDA 510(k) guidance; FDA PMA overview

For a coverage inquiry, identify the exact model, intended use, and applicable regulatory record, then compare the proposed service with the plan's policy. Neither "FDA registered" nor "FDA-cleared" is a promise of insurance payment.

When your situation might qualify — and when it almost certainly will not

5 Reasons Insurers Label Red Light Therapy 'Experimental' and Deny Coverage 3

Comparison of red light therapy scenarios requiring different coverage checks

The answer to will insurance pay for red light therapy depends on the diagnosis, proposed treatment, device, setting, benefit terms, provider requirements, and coding. Home use alone does not determine eligibility, and a clinic setting alone does not establish it.

A situation worth checking is a service specifically addressed by the insurer's policy, delivered under the required clinical protocol, with the necessary records and provider arrangements. Oral mucositis prevention is one example in certain policies. A home panel purchase should not be treated as equivalent to that service.

A situation unlikely to support a medical insurance claim is a panel purchased solely for general wellness, relaxation, or cosmetic skin improvement without an applicable covered benefit. A prescription can document a medical purpose, but it does not override a benefit exclusion. An HSA/FSA receipt belongs to a separate tax-qualified expense assessment, not an insurance coverage decision.

Skin conditions also require careful distinctions. UV phototherapy for psoriasis, photodynamic therapy using a photosensitizing agent, and red-light photobiomodulation are different treatments. Coverage for one does not establish coverage for the others. Do not attribute a denial simply to insurers being slow to follow research; obtain the actual reason stated in the policy or denial notice.

To make the inquiry concrete, ask your insurer or clinic to confirm:

Whether the benefit includes the proposed service or equipment for your diagnosis.
Whether home equipment and clinic treatment are handled differently.
Which provider, network, authorization, and coding requirements apply.
What deductible, copayment, coinsurance, or other patient payment would remain.

Keep the written response or call reference number. An estimate or benefits inquiry should not be treated as an unconditional payment guarantee.

How to actually pursue coverage — a realistic step-by-step path

5 Reasons Insurers Label Red Light Therapy 'Experimental' and Deny Coverage 4

Patient steps for checking red light therapy coverage and separate HSA/FSA eligibility

Q: What is the single most important document to get before attempting any coverage appeal for red light therapy?

Start with the denial notice: it tells you why the request failed and what the appeal must address. A Letter of Medical Necessity can support the clinical case where required or useful, but it is not mandatory for every inquiry and cannot independently overturn an excluded benefit.

Useful clinical documentation may identify the diagnosis, proposed treatment, relevant history, prior treatments, expected clinical goal, and supporting evidence. The treating clinician should describe the actual service rather than rely on general wellness claims.

Step 1: Obtain the Letter of Medical Necessity.

If your insurer or account administrator requires one, ask the treating clinician for a patient-specific letter. Include the proposed device or clinical modality and relevant treatment plan. The clinician or billing team should select diagnosis codes that accurately reflect the medical record.

Step 2: Request your insurer's specific medical policy governing photobiomodulation or low-level laser therapy.

Check both the policy and your benefit documents before purchasing or scheduling. Ask whether prior authorization, a predetermination, or a claim submission is required, and have the clinic submit the required information. For Medicare, check relevant National Coverage Determinations as well as applicable local coverage and billing guidance. NCD 270.6 contains specific infrared non-coverage provisions. CMS NCD 270.6

Step 3: If the initial authorization is denied, file a formal appeal.

Follow the instructions and deadline in the denial notice. Address the stated reason with relevant records, indication-specific research, accurate coding, and device labeling where applicable. Ask about any further review route available under your plan. Manufacturer quality certificates should only be included when relevant; they do not substitute for the clinical evidence or benefit criteria.

Step 4: If the appeal fails, assess HSA/FSA eligibility separately.

You can investigate this before an appeal ends. The IRS definition of medical expenses focuses on diagnosis, treatment, mitigation, or prevention of illness; general health benefits alone do not qualify. A prescription or letter may support substantiation, but the IRS publications do not establish blanket eligibility for every red light therapy device. IRS Publication 502

Check the applicable rules with your FSA administrator or, for HSA tax treatment, a qualified tax adviser. Keep the itemized receipt and evidence of the medical purpose. HSA/FSA spending is separate from insurer reimbursement, and the same expense cannot be reimbursed twice. HSA expenses must also meet account-timing requirements. IRS Publication 969

Q: Does billing for red light therapy in a physical therapy practice work the same way as a patient's prior-authorization request?

The processes can overlap, and the practice may submit requests on the patient's behalf. The billing team must confirm the actual service, current code descriptors, provider requirements, and payer rules. CPT 97026 should not be selected simply because a device emits near-infrared light. Using a code does not create a covered benefit or bypass a non-coverage policy.

What "is red light therapy effective and safe?" means for the coverage debate

5 Reasons Insurers Label Red Light Therapy 'Experimental' and Deny Coverage 5

Researcher reviewing study methods and device specifications for photobiomodulation

Q: Is red light therapy safe enough to use, and does that safety record help with coverage?

Safety depends on the device, exposure, user, and instructions. The American Academy of Dermatology describes generally mild short-term effects, such as temporary discomfort or irritation, while noting that long-term skin and hair effects remain uncertain. People with light-sensitive conditions or medications should seek clinical advice before use. A favorable safety profile alone does not establish coverage. AAD red light therapy guidance

Eye protection should follow the specific device's instructions and risk assessment. IEC 62471 describes photobiological hazard assessment for lamps and lamp systems, including LEDs and excluding lasers. It does not make any generic pair of goggles suitable for every device. IEC 62471:2006

Q: Is red light therapy actually effective, and what does that mean for insurance coverage?

Evidence must be interpreted by indication and protocol. MASCC/ISOO provides clinical guidelines on photobiomodulation for oral mucositis, but a clinical guideline is not an insurer's payment commitment. Evidence for one use should not be extended to broad wellness claims or unrelated device configurations. MASCC/ISOO guideline resources

A study reporting laser output in milliwatts cannot be directly compared with a panel specification in milliwatts per square centimeter. The former is optical power; the latter is irradiance at a defined plane. Compare wavelength, delivered irradiance, beam area, exposure time, pulse settings, treatment location, and patient population. Reporting guidance stresses that missing or unverified parameters undermine reproducibility. Jenkins and Carroll, 2011

For constant irradiance, or a verified time-averaged pulsed measurement, radiant exposure is:

Radiant exposure (J/cm²) = average irradiance (mW/cm²) × exposure time (seconds) ÷ 1,000.

This describes incident energy per area at the measurement plane, not absorbed tissue dose, clinical efficacy, or a treatment prescription. Equal radiant exposure does not establish equivalent treatments. If irradiance is already time-averaged, do not multiply by duty cycle again.

Device architecture also affects how output should be evaluated. A panel with separate red and NIR emitters may activate only some emitter locations in single-channel modes. NIR-only emission is not visibly red, so visual inspection alone cannot determine whether the NIR channel works. The irradiance distribution requires measurement rather than an assumption based on how bright the panel looks.

Dual-chip LED packages can place red and NIR emitters at the same locations, while independently controlled channels allow separate output adjustment. Optical mapping, electrical measurements, and temperature testing are still needed to verify uniformity, output, and power utilization. The architecture alone does not establish clinical equivalence or insurance eligibility.

Wavelength consistency, thermal management, and electrical and electromagnetic compatibility checks support reliable device operation. They complement clinical evidence; they do not replace it.

Key Takeaways

Will insurance pay for red light therapy? Check the exact indication and plan before spending. Some policies identify limited clinical uses, while Medicare expressly excludes specified infrared applications. Registration, clearance, quality-system certification, diagnosis codes, and medical-necessity letters serve different purposes and do not independently guarantee payment. HSA/FSA eligibility is a separate assessment of qualifying medical expenses.

FAQ

How to get insurance to pay for red light therapy?

Ask your insurer for the applicable policy and benefit rules, then have your clinician or clinic identify the proposed service, diagnosis, device, and documentation. Complete any required authorization before treatment. If denied, appeal according to the notice and address its stated reason. Payment depends on the plan's criteria, not the presence of a prescription alone.

What is the downside of red light therapy?

Possible drawbacks include uncertain benefit for the intended use, repeated sessions, cost, and device-dependent adverse effects. Follow model-specific instructions for exposure and eye protection. Light-sensitive conditions or medications can make clinical advice necessary. Do not assume that a brighter device or longer session produces a better result. AAD guidance

How much does one session of red light therapy cost?

There is no single national price for this category. Ask the provider for a written estimate identifying the modality, session length, treatment area, clinician involvement, recommended visits, and additional fees. Compare the full expected course with any home-device option your clinician considers appropriate. A clinic service and a home panel are not automatically equivalent.

The AAD reports that consumer red-light devices often cost from about $100 to more than $1,000. This is a broad consumer device-price range; obtain a separate estimate for clinic sessions. AAD guidance

What qualifies for red light therapy?

Clinical suitability, device intended use, insurance eligibility, and HSA/FSA eligibility are separate questions. A clinician assesses whether the proposed treatment is appropriate. Verify any claimed FDA-cleared use against the exact model's labeling, then check whether the insurer covers that service for the diagnosis. General wellness or cosmetic use does not automatically satisfy the IRS definition of a medical expense. IRS Publication 502

5 Reasons Insurers Label Red Light Therapy 'Experimental' and Deny Coverage